BackgroundDespite international concern about unregulated predictive genetic testing, there are surprisingly few data on both the determinants of community interest in such testing and its psychosocial impact.MethodA large population-based public survey with community-dwelling adults (n=1046) ascertained through random digit dialling. Attitudes were assessed by structured interviews.ResultsThe study found strong interest in predictive genetic testing for a reported susceptibility to depression. Once the benefits and disadvantages of such testing had been considered, there was significantly greater interest in seeking such a test through a doctor (63%) compared to direct-to-consumer (DTC; 40%) (p<0.001). Personal history of mental illness [odds ratio (OR) 2.58,p<0.001], self-estimation of being at higher than average risk for depression (OR 1.92,p<0.001), belief that a genetic component would increase rather than decrease stigma (OR 1.62,p<0.001), and endorsement of benefits of genetic testing (OR 3.47,p<0.001) significantly predicted interest in having such a test.ConclusionsDespite finding attitudes that genetic links to mental illness would increase rather than decrease stigma, we found strong community acceptance of depression risk genotyping, even though a predisposition to depression may only manifest upon exposure to stressful life events. Our results suggest that there will be a strong demand for predictive genetic testing.